logo
15:54 Dec 05

Neuland Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
16887.00
-108.00 (-0.64%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Neuland Laboratories Ltd. Financials

Neuland Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
16887.00
-108.00 (-0.64%)
15:54 Dec 05
Quality
image/svg+xml

57/100
High Financial Strength

Valuation
image/svg+xml

23/100
Expensive Valuation

Technical

61/100
Technically Moderately Bullish

Strength

9

Weakness

2

Opportunity

1

Threats

0

17.06 %

ROE %

11.93 %

ROA %

187.18

EPS

1,181.32

BVPS

17.61 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
951.08 1191.2 1558.58 1476.84 1329.98
Operating Expenses +
808.45 919.35 1095.99 1153.57 1095.61
Raw Material
437.55 487.74 632.43 574.81 581.33
Increase Decrease in Cost
-15.41 -9.51 -55.14 12.83 -57.03
Other Manufacturing Expense
131.36 135.56 156.51 162.87 0
Employee Cost
182.47 201.79 257.06 272 272.34
Miscellaneous Expenses
72.48 103.77 105.13 131.06 298.97
Operating Profit
142.63 271.85 462.59 323.27 234.37
Other Income
2.08 9.75 12.54 20.51 23.56
Depreciation
49.04 52.78 59.7 65.55 69.45
Interest
13.5 13.07 14 8.3 10.21
Profit before tax and exceptio..
82.16 215.75 401.44 269.93 178.27
Exceptional Items
0 0 0 76.4 55.78
PBT
82.16 215.75 401.44 346.33 122.49
Provision for Taxation
18.34 52.23 101.36 86.22 57.92
Net Profit
63.82 163.52 300.08 260.11 176.14
NET Profit after MI
63.82 163.52 300.08 260.11 176.14
EPS
49.74 127.45 233.89 202.74 137.28
Operating Profit Margin (%)
15 22.82 29.68 21.89 17.62
Net Profit Margin (%)
6.71 13.73 19.25 17.61 13.24

Neuland Laboratories Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: